Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

Ferro, Matteo; Katalin, Martha Orsolya; Buonerba, Carlo; Marian, Raluca; Cantiello, Francesco; Musi, Gennaro; Di Stasi, Savino; Hurle, Rodolfo; Guazzoni, Giorgio; Busetto, Gian Maria; Del Giudice, Francesco; Perdonà, Sisto; Del Prete, Paola; Mirone, Vincenzo; Borghesi, Marco; Porreca, Angelo; Artibani, Walter; Bove, Pierluigi; Lima, Estevao; Autorino, Riccardo; Crisan, Nicolae; Abu Farhan, Abdal Rahman; Battaglia, Michele; Ditonno, Pasquale; Serretta, Vincenzo; Russo, Giorgio Ivan; Terracciano, Daniela; Di Lorenzo, Giuseppe; Damiano, Rocco; Sonpavde, Guru; Vartolomei, Mihai Dorin; De Cobelli, Ottavio; Lucarelli, Giuseppe

doi:10.1016/j.urolonc.2020.02.016

The aim of this multicenter study was to investigate the prognostic role of type 2 diabetes mellitus (T2DM) comorbidity in a large multi-institutional cohort of patients with primary T1HG/G3 non-muscle-invasive bladder cancer (NMIBC) treated with transurethral resection of the bladder (TURB).

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor / Ferro, M., Katalin, M.O., Buonerba, C., Marian, R., Cantiello, F., Musi, G., Di Stasi, S., Hurle, R., Guazzoni, G., Busetto, G.M., Del Giudice, F., Perdonà, S., Del Prete, P., Mirone, V., Borghesi, M., Porreca, A., Artibani, W., Bove, P., Lima, E., Autorino, R., et al.. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - (2020). [10.1016/j.urolonc.2020.02.016]